Migration and mobility, the sex work risk environment, and HIV/STIs: Mixed-methods research with female sex workers and their male clients

Speaker:

Shira Goldenberg
Shira Goldenberg is a Postdoctoral Research Fellow with the Gender and Sexual Health Initiative of the BC Centre for Excellence in HIV/AIDS and the Division of AIDS in the Department of Medicine at UBC. She is a global health researcher who has been conducting qualitative, quantitative, and mixed methods research on social and structural factors shaping HIV and sexually transmitted infections among mobile, vulnerable populations in Canada and Latin America since 2006. Her current research aims to explore how migration and mobility patterns influence the health and safety of migrant sex workers in Vancouver and along the Mexico/Guatemala border.

For more information, click HERE


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below